International Biotechnology Trust plc (IBT.L)
GBp 630.0
(-0.32%)
GBp 630.0
(-0.32%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 39.55 Million GBP | 0.0% |
| 2023 | - GBP | 132.02% |
| 2022 | - GBP | -177.22% |
| 2021 | - GBP | -47.67% |
| 2020 | - GBP | 407.23% |
| 2019 | - GBP | -186.25% |
| 2018 | - GBP | -55.57% |
| 2017 | - GBP | 759.97% |
| 2016 | - GBP | -108.77% |
| 2015 | - GBP | 75.42% |
| 2014 | - GBP | 0.86% |
| 2013 | - GBP | 16.83% |
| 2012 | - GBP | 726.42% |
| 2011 | 4.6 Million GBP | 331.37% |
| 2010 | 1.06 Million GBP | 112.83% |
| 2009 | -8.32 Million GBP | 0.0% |
| 2007 | -2.11 Million GBP | -121.51% |
| 2006 | 9.85 Million GBP | 2762.43% |
| 2005 | -370 Thousand GBP | -130.25% |
| 2004 | 1.22 Million GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -315.5 Thousand GBP | -282.9% |
| 2024 Q2 | -315.5 Thousand GBP | 0.0% |
| 2023 Q2 | 17.01 Million GBP | 850400.0% |
| 2023 Q1 | 2000.00 GBP | -99.99% |
| 2023 Q4 | 172.5 Thousand GBP | 0.0% |
| 2023 Q3 | 172.5 Thousand GBP | -98.99% |
| 2023 FY | - GBP | 132.02% |
| 2022 Q3 | -2.08 Million GBP | 95.62% |
| 2022 Q2 | -47.66 Million GBP | -10909.01% |
| 2022 Q1 | -433 Thousand GBP | -104.84% |
| 2022 FY | - GBP | -177.22% |
| 2022 Q4 | 30.38 Million GBP | 1555.71% |
| 2021 FY | - GBP | -47.67% |
| 2021 Q1 | -69.5 Thousand GBP | -100.16% |
| 2021 Q2 | 19.24 Million GBP | 27794.96% |
| 2021 Q3 | -7000.00 GBP | -100.04% |
| 2021 Q4 | 8.95 Million GBP | 127985.71% |
| 2020 FY | - GBP | 407.23% |
| 2020 Q3 | 559.5 Thousand GBP | -93.76% |
| 2020 Q4 | 43.12 Million GBP | 7607.95% |
| 2020 Q2 | 8.96 Million GBP | 4544.04% |
| 2020 Q1 | 193 Thousand GBP | -96.85% |
| 2019 FY | - GBP | -186.25% |
| 2019 Q1 | -8500.00 GBP | 0.0% |
| 2019 Q2 | -8500.00 GBP | 0.0% |
| 2019 Q3 | -357 Thousand GBP | -4100.0% |
| 2019 Q4 | 6.12 Million GBP | 1815.41% |
| 2018 FY | - GBP | -55.57% |
| 2018 Q4 | -8500.00 GBP | 0.0% |
| 2018 Q1 | 424 Thousand GBP | 104.34% |
| 2018 Q2 | 424 Thousand GBP | 0.0% |
| 2018 Q3 | -8500.00 GBP | -102.0% |
| 2017 Q1 | -311.5 Thousand GBP | 36.3% |
| 2017 FY | - GBP | 759.97% |
| 2017 Q4 | 207.5 Thousand GBP | 0.0% |
| 2017 Q3 | 207.5 Thousand GBP | 166.61% |
| 2017 Q2 | -311.5 Thousand GBP | 0.0% |
| 2016 Q2 | -783.5 Thousand GBP | 0.0% |
| 2016 Q3 | -489 Thousand GBP | 37.59% |
| 2016 Q4 | -489 Thousand GBP | 0.0% |
| 2016 Q1 | -783.5 Thousand GBP | -2649.12% |
| 2016 FY | - GBP | -108.77% |
| 2015 Q2 | -267 Thousand GBP | 0.0% |
| 2015 Q1 | -267 Thousand GBP | -2710.53% |
| 2015 FY | - GBP | 75.42% |
| 2015 Q3 | -28.5 Thousand GBP | 89.33% |
| 2015 Q4 | -28.5 Thousand GBP | 0.0% |
| 2014 Q2 | -41 Thousand GBP | 0.0% |
| 2014 Q1 | -41 Thousand GBP | 54.7% |
| 2014 Q3 | -9500.00 GBP | 76.83% |
| 2014 FY | - GBP | 0.86% |
| 2014 Q4 | -9500.00 GBP | 0.0% |
| 2013 Q4 | -90.5 Thousand GBP | 0.0% |
| 2013 Q1 | -18 Thousand GBP | -180.0% |
| 2013 FY | - GBP | 16.83% |
| 2013 Q3 | -90.5 Thousand GBP | -402.78% |
| 2013 Q2 | -18 Thousand GBP | 0.0% |
| 2012 FY | - GBP | 726.42% |
| 2012 Q4 | 22.5 Thousand GBP | 0.0% |
| 2012 Q2 | 9.51 Million GBP | 0.0% |
| 2012 Q3 | 22.5 Thousand GBP | -99.76% |
| 2011 Q3 | 1.15 Million GBP | 0.0% |
| 2011 FY | - GBP | 331.37% |
| 2011 Q4 | 1.15 Million GBP | 0.0% |
| 2011 Q2 | 1.15 Million GBP | 0.0% |
| 2010 Q2 | 267 Thousand GBP | 0.0% |
| 2010 Q3 | 267 Thousand GBP | 0.0% |
| 2010 Q4 | 267 Thousand GBP | 0.0% |
| 2010 FY | - GBP | 112.83% |
| 2009 Q4 | -2.08 Million GBP | 0.0% |
| 2009 Q2 | -2.08 Million GBP | 0.0% |
| 2009 FY | - GBP | 0.0% |
| 2009 Q3 | -2.08 Million GBP | 0.0% |
| 2007 Q2 | -529.75 Thousand GBP | 0.0% |
| 2007 Q3 | -529.75 Thousand GBP | 0.0% |
| 2007 Q4 | -529.75 Thousand GBP | 0.0% |
| 2007 FY | - GBP | -121.51% |
| 2006 Q4 | 2.46 Million GBP | 0.0% |
| 2006 FY | - GBP | 2762.43% |
| 2006 Q2 | 2.46 Million GBP | 0.0% |
| 2006 Q3 | 2.46 Million GBP | 0.0% |
| 2005 Q3 | -92.5 Thousand GBP | 0.0% |
| 2005 FY | - GBP | -130.25% |
| 2005 Q2 | -92.5 Thousand GBP | 0.0% |
| 2005 Q4 | -92.5 Thousand GBP | 0.0% |
| 2004 FY | - GBP | 0.0% |
| 2004 Q4 | 305.75 Thousand GBP | 0.0% |
| 2004 Q2 | 305.75 Thousand GBP | 0.0% |
| 2004 Q3 | 305.75 Thousand GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|